Harpoon's fall continues as CMO departs weeks after lead program axed
With the lead clinical program out the door last month, Harpoon Therapeutics’ chief medical officer is also exiting the small biotech that has had little …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
